News

Filter

Current filters:

GlaxoSmithKline

1 to 9 of 3616 results

Vaccines a $25.5 billion business in 2014; report

Vaccines a $25.5 billion business in 2014; report

13-02-2015

Vaccines are a big business, and a growing business, says health care market researcher Kalorama Information,…

GlaxoSmithKlineMarkets & MarketingMerck & CoNovartisPfizerPharmaceuticalSanofiVaccines

UPDATE: GSK acquires remainder of GlycoVaxyn for $190 million

UPDATE: GSK acquires remainder of GlycoVaxyn for $190 million

11-02-2015

UK pharma major GlaxoSmithKline this morning said that it has acquired Switzerland-based GlycoVaxyn,…

GlaxoSmithKlineGlycoVaxynMergers & AcquisitionsPharmaceuticalVaccines

GlaxoSmithKline encounters initial resistance following directional shift, says analyst

GlaxoSmithKline encounters initial resistance following directional shift, says analyst

10-02-2015

Following a less than flattering financial performance in 2014, UK pharma major GlaxoSmithKline is realigning…

FinancialGlaxoSmithKlineOncologyPharmaceuticalRespiratory and Pulmonary

GSK files for EU expanded indication for Revolade

GSK files for EU expanded indication for Revolade

06-02-2015

UK pharma major GlaxoSmithKline has filed a submission with the European Medicines Agency for a variation…

eltrombopagEuropeGlaxoSmithKlinePharmaceuticalRare diseasesRegulationRevolade

IQWiG sees benefits for Triumeq and Eperzan

05-02-2015

Germany’s Institute for Quality and Efficiency in Health Care (IQWiG) has announced its latest findings…

Anti-viralsDiabetesEperzanGermanyGlaxoSmithKlinePharmaceuticalPricingRegulationTriumeqViiV Healthcare

2014 tough year for GlaxoSmithKline, but 4th qtr EPS beats forecasts

2014 tough year for GlaxoSmithKline, but 4th qtr EPS beats forecasts

04-02-2015

UK pharma major GlaxoSmithKline saw its shares rise 2.8% to £14.94 shortly after reporting fourth-quarter…

Core EPsFinancialGlaxoSmithKlinePharmaceuticalViiV Healthcare

GSK and Novartis get European clearance for asset swap

GSK and Novartis get European clearance for asset swap

29-01-2015

UK pharma major GlaxoSmithKline has received clearance from the European Commission for its proposed…

EuropeFinancialGlaxoSmithKlineNovartisOncologyPharmaceuticalUK

Milestone for GSK/NIH candidate Ebola vaccine as first doses shipped for Phase III trial

Milestone for GSK/NIH candidate Ebola vaccine as first doses shipped for Phase III trial

23-01-2015

UK pharma major GlaxoSmithKline said this morning that the first batch of its candidate Ebola vaccine…

EbolaGlaxoSmithKlinePharmaceuticalResearchUKVaccines

1 to 9 of 3616 results

COMPANY SPOTLIGHT

Menarini

Back to top